Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users

American Journal of Medicine

Volumn 102, Issue 3, 1997, Pages 232-238

  Sullivan, John T ^a,b   Becker, Patrice M ^a   Preston, Kenzie L ^a   Wise, Robert A ^a   Wigely, Frederick M ^a   Testa, Margaret P ^a   Jasinski, Donald R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; CHRONOTROPISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; HUMAN; LASER DOPPLER FLOWMETRY; LUNG DIFFUSION CAPACITY; MALE; PRESSOR RESPONSE; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN TEMPERATURE; SUBSTANCE ABUSE; VASCULAR DISEASE; VASOCONSTRICTION;

ADULT; CARBON MONOXIDE; CHRONIC DISEASE; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FINGERS; HUMANS; INFANT, NEWBORN; LASER-DOPPLER FLOWMETRY; MALE; NARCOTICS; PULMONARY DIFFUSING CAPACITY; QUESTIONNAIRES; REGIONAL BLOOD FLOW; SKIN; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 0030985265     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00453-6     Document Type: Conference Paper

References (34)

1. Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol. 1993;72:3-12.
2. Boehrer JD, Moliterno DJ, Willard JE, et al. Hemodynamic effects of intranasal cocaine in humans. J Am Coll Cardiol. 1992;20:90-93.
3. Preston KL, Sullivan JT, Strain EC, Bigelow GE. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther. 1992;262:279-291.
4. Gawin FH, Ellinwood EH. Cocaine and other stimulants. Actions, abuse and treatment. NEJM. 1988;318:1173-1182.
5. Jaffe JE. Drug addiction and drug abuse. In Goodman Gilman A, Rail TW, Nies AS, Taylor P (eds.), The Pharmacologic Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990;522-573.
6. Somlyo AP, Somlyo AV. Vascular smooth muscle. II. Pharmacology of normal and hypertensive vessels. Pharmacological Reviews. 1970;22:249-349.
7. Wise RA. Neural mechanisms of the reinforcing action of cocaine. In Grabowski J (ed). Cocaine: Pharmacology, Effects, and Treatment of Abuse. National Institute of Drug Abuse Research Monograph 50. DHHS Pub. No. (ADM)87-1326. Washington DC: SUPT. of Docs., US Govt Print Off, 1984;15-33.
8. Knuepfer MM, Branch CA, Fisher VW. Mechanisms of cardiac and vascular responses to cocaine. In Thadani P (ed). Cardiovascular Toxiciry of Cocaine: Underlying Mechanisms. National Institute of Drug Abuse Research Monograph 108. DHHS Pub. No. (ADM)91-1767. Washington DC: SUPT. of Docs., US Govt Print Off, 1991;55-73.
9. Lange RA, Cigarroa RG, Yancy CW, et al. Cocaine-induced coronary artery vasoconstriction. NEJM. 1989;321:1557-1562.
10. London ED, Cascalla NG, Wong DF, et al. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18] fluorodeoxyglucose. Arch Gen Psychiatry. 1990;47:567-574.
11. Pearlson GD, Jeffery PJ, Harris GJ, et al. Correlation of acute cocaineinduced changes in local cerebral blood flow with subjective effects. Am J Psychiatry. 1993;150:495-497.
12. Cregler LL, Mark H. Medical complications of cocaine abuse. NEJM. 1986;315:1495-1500.
13. Murray RJ, Smialek JE, Golle M, Albin RJ. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest. 1989;96:1050-1053.
14. Overland ES, Nolan AJ, Haperwell PC. Alteration of pulmonary function in intravenous drug abusers. Am J Med. 1980;68:231-237.
15. Itkonen J, Schnoll S, Glassroth J. Pulmonary dysfunction in "freebase" cocaine users. Arch Intern Med. 1984;144:2195-2197.
16. Tashkin DP, Gorelick D, Khalsa ME, et al. Respiratory effects of cocaine freebasing among habitual cocaine users. J Addictive Diseases. 1992;11:59-70.
17. Weiss RD, Tilles DS, Goldenheim PD, Mirin SM. Decreased single breath carbon monoxide diffusing capacity in cocaine freebase smokers. Drug Alcohol Dependence. 1987;19:271-276.
18. Preston KL, Sullivan JT, Berger P, Bigelow GE. Effects of cocaine alone and in combination with mazindol in human cocaine abusers. J Pharmacol Exp Ther. 1993;267:296-307.
19. Boccalon HJ, Marguery MC, Ginestet MC, Puel PF. Laser doppler flowmeter and standardized thermal test in normals and Raynaud's phenomenon. Int Angiol. 1987;6:107-118.
20. Wigley FM, Wise RA, Mikdashi J, et al. The post-occlusive hyperemic response in patients with systemic sclerosis. Arthritis Rheum. 1990;33:1620-1625.
21. Jasinski DR, Sullivan JT, Cone E, et al. Pharmacodynamic and pharmacokinetic comparison of subcutaneously (sc) and intravenously (iv) given cocaine. Clin Pharmacol Ther. 1993;53:174.
22. American Thoracic Society. Single breath carbon monoxide diffusing capacity (Transfer Factor): Recommendations for a standard technique. Am Rev Resp Dis. 1987;136:1299-1307.
23. Cochran WG, Cox GM. Experimental Designs. 2nd ed. New York: John Wiley and Sons, Inc; 1957.
24. Noe DA, Kumor KM. A pharmacokinetic-pharmacodynamic model of heart rate during cocaine administration in humans. Clin Pharmacol Ther. 1991;49:426-432.
25. Brogan WC, Lange RA, Glamann DB, Hillis LD. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med. 1992;116:556-561.
26. Snedecor GW. Statistical Methods. 5th ed. Ames, lowa: The lowa State University Press; 1956.
27. Hamm LF, Stull GA, Crow RS. Exercise testing early after myocardial infarction: historic perspective and current uses. Prog Cardiovasc Dis. 1986; 28:463-476.
28. Andrews HP, Snee RD, Sarner MN. Graphical display of means. Am Statistician. 1980;34:195-199.
29. Chow MJ, Ambre JJ, Ruo T, et al. Kinetics of cocaine distribution, elimination, and chronotropic effects. Clin Pharmacol Ther. 1985;38:318-324.
30. Fischman MW, Schuster CR, Resnekov L, et al. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry. 1976;33:983-989.
31. Kumor K, Sherer M, Thompson L, et al. Lack of cardiovascular tolerance during intravenous cocaine infusion in human volunteers. Life Sci. 1988;42:2063-2071.
32. Jacobsen TN, Snyder RW, Grayburn PA, et al. Intranasal cocaine decreases sympathetic nerve activity in humans. Circulation. 1993;88:l-85.
33. Shannon RP, Manders WT, Shen YT. Role of blood doping in the coronary vasoconstrictor response to cocaine. Circulation. 1995;92:96-105.
34. Budney AJ, Higgins ST, Hughes JR, Bickel WK. Nicotine and caffeine use in cocaine-dependent individuals. J Substance Abuse. 1993;5:117-130.